An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias

NCT05757570 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Immune Thrombocytopenia
Idiopathic Thrombocytopenic Purpura
Warm Autoimmune Hemolytic Anemia
Cold Agglutinin Disease

Interventions

DRUG: povetacicept

Sponsor

Alpine Immune Sciences, Inc.